Patents by Inventor Sharyn Wilson

Sharyn Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of detecting cancer
    Patent number: 11391738
    Abstract: The disclosure provides methods for resolving an inconclusive cytological assessment of clinically relevant cells in a sample obtained from a patient based on the cytological detection of an antibody binding to a diagnostic protein in the clinically relevant cells in the sample.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: July 19, 2022
    Assignee: Sienna Cancer Diagnostics Ltd
    Inventors: Minesh Lalla, Fabio Turatti, Sharyn Wilson
  • Method of Detecting Cancer
    Publication number: 20200049715
    Abstract: The disclosure provides methods for resolving an inconclusive cytological assessment of clinically relevant cells in a sample obtained from a patient based on the cytological detection of an antibody binding to a diagnostic protein in the clinically relevant cells in the sample.
    Type: Application
    Filed: May 20, 2019
    Publication date: February 13, 2020
    Inventors: Minesh Lalla, Fabio Turatti, Sharyn Wilson
  • Method of detecting cancer
    Patent number: 10338072
    Abstract: The disclosure provides methods for resolving an inconclusive cytological assessment of clinically relevant cells in a sample obtained from a patient based on the cytological detection of antibody binding to telomerase in clinically relevant cells in the sample, wherein binding of the antibody to clinically relevant cells indicates the presence of malignant or cancerous cells.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: July 2, 2019
    Assignee: Sienna Cancer Diagnostics Ltd
    Inventors: Minesh Lalla, Fabio Turatti, Sharyn Wilson
  • Method of Detecting Cancer
    Publication number: 20170176438
    Abstract: The disclosure provides methods for resolving an inconclusive cytological assessment of clinically relevant cells in a sample obtained from a patient based on the cytological detection of antibody binding to telomerase in clinically relevant cells in the sample, wherein binding of the antibody to clinically relevant cells indicates the presence of malignant or cancerous cells.
    Type: Application
    Filed: February 17, 2015
    Publication date: June 22, 2017
    Inventors: Minesh Lalla, Fabio Turatti, Sharyn Wilson